We are pleased to welcome James Ernst, PhD, Vice President of Development Sciences at Xencor and Krys Corbett, Chief Business Officer at Pacira Biosciences, to the Board of Directors of The Antibody Society.
James and Krys bring broad scientific, legal and strategic expertise spanning business development, portfolio strategy, protein sciences, and translational development. Their perspectives will further strengthen the Society’s role as an international forum supporting antibody research, engineering, and therapeutic development across all career stages.
We are grateful for their willingness to serve and look forward to their contributions as we continue advancing the therapeutic antibody field.
